← All trials
NCT03159507
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 2, 2017
- Primary completion
- Mar 14, 2019
- Completion date
- Mar 14, 2019
- First posted
- May 18, 2017
- Last posted
- Apr 4, 2019
- Enrollment
- 16
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- SCF PharmaLead sponsor
- SCF PharmaStudy director
- University of QuebecCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.